Why Email Compliance Matters More for Medical Device Companies
Email compliance isn't just a legal checkbox for medical device marketers. It's a business imperative that affects your deliverability, your brand reputation, and your ability to maintain long-term relationships with healthcare professionals. Getting it wrong doesn't just risk fines and legal action. It can damage your sender reputation, trigger spam filters across entire hospital systems, and erode the trust you've spent years building with surgeons, administrators, and procurement teams.
Medical device companies face a unique compliance challenge because they operate at the intersection of multiple regulatory frameworks. Beyond the standard email marketing laws that apply to all commercial senders, medical device marketers must also navigate FDA regulations around promotional communications, healthcare-specific privacy rules, and the professional expectations of an audience that takes regulatory compliance very seriously.
At Buzzbox Media in Nashville, we help medical device companies build email programs that are both effective and fully compliant. This guide covers the three major email compliance frameworks that medical device marketers need to understand: CAN-SPAM in the United States, GDPR in the European Union, and CASL in Canada. We also cover FDA promotional compliance as it applies to email marketing and provide practical implementation guidance for building compliant email operations.
CAN-SPAM: United States Email Compliance
What CAN-SPAM Requires
The Controlling the Assault of Non-Solicited Pornography And Marketing Act, commonly known as CAN-SPAM, is the primary law governing commercial email in the United States. Enacted in 2003, it establishes requirements for commercial messages, gives recipients the right to opt out, and outlines penalties for violations.
CAN-SPAM applies to any commercial email message, which the law defines broadly as any electronic mail message whose primary purpose is the commercial advertisement or promotion of a commercial product or service. For medical device companies, this includes product promotion emails, newsletters with commercial content, event invitations designed to promote products, and follow-up emails with commercial intent.
The key requirements of CAN-SPAM include the following:
- Accurate header information: The "From," "To," and "Reply-To" fields must accurately identify the person or business sending the message. Don't use misleading sender names or reply addresses
- Non-deceptive subject lines: The subject line must accurately reflect the content of the message. Clickbait subject lines that promise content the email doesn't deliver violate this requirement
- Identification as advertising: The law requires that commercial emails be identified as advertisements. There is flexibility in how this is done, and the requirement can be satisfied through clear commercial context without an explicit "this is an ad" label
- Physical address: Every commercial email must include the sender's valid physical postal address. This can be a street address, a registered post office box, or a private mailbox registered with a commercial mail receiving agency
- Opt-out mechanism: Every commercial email must include a clear and conspicuous way for the recipient to opt out of future commercial emails. The opt-out mechanism must be functional for at least 30 days after the email is sent
- Prompt opt-out processing: Opt-out requests must be honored within 10 business days. You cannot charge a fee, require the recipient to provide additional information beyond their email address, or make them take more than a single step to opt out
- Third-party compliance: If you hire another company to handle your email marketing, both the company whose product is promoted and the company sending the message can be held legally responsible for compliance
What CAN-SPAM Does Not Require
Unlike GDPR and CASL, CAN-SPAM does not require prior opt-in consent before sending commercial emails. You can legally send commercial email to anyone in the United States as long as you comply with the requirements listed above. However, just because you can doesn't mean you should. Sending unsolicited emails to contacts who haven't opted in typically results in poor engagement, high spam complaints, and damaged sender reputation.
CAN-SPAM Penalties
Violations of CAN-SPAM can result in penalties of up to $51,744 per email, per violation. Additionally, the FTC has the authority to pursue injunctive relief and other enforcement actions. While enforcement against individual senders is relatively rare, the financial exposure is significant enough that compliance should be taken seriously.
For more on how compliance fits into your overall email strategy, our medical device marketing guide provides additional context.
GDPR: European Email Compliance
When GDPR Applies to Medical Device Companies
The General Data Protection Regulation applies to any organization that processes personal data of individuals in the European Union, regardless of where the organization is based. If your medical device company has customers, prospects, or contacts in EU member states, GDPR applies to your email marketing activities directed at those individuals.
This is critically important for medical device companies with international sales operations, European distributor relationships, or attendance at European medical conferences like MEDICA, the European Congress of Radiology, or EAES. If you scan badges or collect contact information at European events, GDPR governs how you can use that data for email marketing.
GDPR Consent Requirements
GDPR sets a much higher bar for consent than CAN-SPAM. Under GDPR, consent for email marketing must be freely given, specific and informed, unambiguous through a clear affirmative action, and as easy to withdraw as it was to give.
In practical terms, this means pre-checked consent boxes are not valid. Consent bundled with terms and conditions is not valid. Consent obtained through deceptive or unclear language is not valid. And silence or inactivity does not constitute consent.
You must clearly explain what the contact is signing up for, how their data will be used, and who will be contacting them. The consent request must be separate from other terms or agreements, and the contact must take a deliberate action (like checking an unchecked box or clicking a specific button) to grant consent.
Legitimate Interest as an Alternative to Consent
GDPR provides an alternative legal basis for processing personal data called "legitimate interest." Some medical device companies rely on legitimate interest rather than explicit consent for certain types of email communication, particularly in B2B contexts where there is an existing business relationship.
Using legitimate interest requires a balancing test: your legitimate business interest in sending the email must be weighed against the individual's rights and expectations. For B2B marketing to business contacts at their work email addresses, legitimate interest can be a valid legal basis, but it requires documentation of the balancing test and a clear opt-out mechanism.
Legitimate interest is not a blanket permission to email anyone without consent. It's a carefully considered legal basis that requires documentation, transparency, and an easy opt-out. When in doubt, consent is always the safer approach.
Data Subject Rights Under GDPR
GDPR grants individuals extensive rights over their personal data that directly affect your email marketing operations. These include the right to access their data and know how it's being used, the right to rectification if their data is incorrect, the right to erasure, also known as the right to be forgotten, the right to restrict processing in certain circumstances, the right to data portability, and the right to object to processing, including direct marketing.
Your email marketing operations must have processes in place to respond to these requests within the legally required timeframe, which is generally 30 days. This means your marketing automation platform and CRM must support data export, deletion, and processing restrictions at the individual contact level.
GDPR Penalties
GDPR penalties are severe. Maximum fines are the greater of 20 million euros or 4% of annual global revenue. While penalties at this level are reserved for the most serious violations, smaller fines in the hundreds of thousands to low millions of euros have been issued to companies for email marketing violations. The reputational damage of a GDPR enforcement action can be equally costly.
CASL: Canadian Email Compliance
What Makes CASL Different
Canada's Anti-Spam Legislation is often considered the strictest anti-spam law in the world. It applies to any commercial electronic message sent to or from Canada, which means medical device companies with Canadian customers, prospects, or distributors must comply.
CASL's defining characteristic is its consent model. Unlike CAN-SPAM's opt-out approach, CASL requires either express consent or implied consent before you can send commercial electronic messages.
Express vs. Implied Consent Under CASL
Express consent is given when the recipient explicitly agrees to receive commercial electronic messages from you, typically through a sign-up form, a checked checkbox (not pre-checked), or a verbal agreement (though written records are advisable). Express consent does not expire unless the recipient withdraws it.
Implied consent exists in certain defined circumstances and has time limitations. Implied consent exists when there is an existing business relationship (the recipient purchased from you or entered a contract with you within the past two years), when there is an existing non-business relationship (the recipient made a donation, membership, or volunteer contribution within the past two years), and when the recipient has conspicuously published their email address without a statement that they don't want unsolicited commercial messages.
For medical device companies, the existing business relationship provision is particularly relevant. If a hospital has purchased your products within the past two years, you have implied consent to email contacts at that hospital. However, implied consent from a purchase expires after two years, so you need a strategy for converting implied consent contacts to express consent before the window closes.
CASL Content Requirements
Every commercial electronic message sent under CASL must include your identity or the identity of the person on whose behalf the message is sent, your physical mailing address and either a phone number, email address, or web address, and a functional unsubscribe mechanism that works for at least 60 days after the message is sent.
Unsubscribe requests must be processed within 10 business days, and you cannot require the recipient to provide additional personal information or pay a fee to unsubscribe.
CASL Penalties
CASL provides for administrative monetary penalties of up to $10 million per violation for businesses. The Canadian Radio-television and Telecommunications Commission (CRTC) has actively enforced CASL, issuing significant penalties to companies that failed to obtain proper consent or honor unsubscribe requests.
FDA Promotional Compliance for Email Marketing
Beyond anti-spam laws, medical device companies must also comply with FDA regulations when their emails contain promotional content about their products.
Promotional vs. Non-Promotional Email Content
The FDA distinguishes between promotional and non-promotional communications. Promotional communications are those that promote the commercial use of a medical device and are subject to FDA regulatory oversight. Non-promotional communications, such as disease awareness education, operational updates, and general industry news, are not subject to the same promotional regulations.
In the email context, this distinction matters because promotional emails must comply with FDA promotional requirements including claims consistent with cleared or approved indications for use, adequate risk disclosure and fair balance, substantiated clinical claims with proper attribution, and prohibition of off-label promotion.
Non-promotional educational content in your newsletter doesn't carry these requirements, but the line between educational and promotional can be blurry. When in doubt, have your regulatory affairs team review email content before it's sent.
Fair Balance in Email Communications
When your email promotes a specific device, FDA guidance expects fair balance between benefit claims and risk information. In practice, this means including relevant contraindications, warnings, and precautions when making specific product claims. The challenge in email marketing is presenting this information in a format that's compliant without burying your marketing message.
Common approaches include linking to the full Important Safety Information (ISI) on your website with a clear disclosure statement in the email, including a condensed risk summary in the email footer, and structuring the email so that product claims and risk information are presented with comparable prominence.
Work closely with your regulatory affairs team to establish email-specific promotional review guidelines that address the unique constraints and opportunities of the email format.
Email Promotional Review Process
Every email that contains promotional content about your medical devices should go through your company's promotional review process before being sent. This process typically involves medical, legal, and regulatory (MLR) review to ensure claims are substantiated and compliant, documentation and archival of approved email content, version control to ensure that only approved content is used in active campaigns, and periodic re-review as clinical evidence, indications, and competitive positioning evolve.
Build the promotional review timeline into your email production workflow. If your MLR review process takes two weeks, your email production timeline needs to account for that. Rushing compliance review leads to either delays or insufficiently reviewed content, both of which are bad outcomes.
Our medical device marketing services include compliance-aware email strategy that integrates regulatory requirements into the campaign planning process.
Practical Implementation Guide
Building a Compliant Consent Management System
Your email platform needs robust consent management capabilities. At minimum, your system should track the source and date of consent for every contact, distinguish between express and implied consent (critical for CASL), record the specific communications the contact consented to receive, maintain a complete audit trail of consent changes, and support automated consent expiration for time-limited implied consent.
Most modern marketing automation platforms, including HubSpot and Marketo, provide GDPR and consent management features. Configure these features during initial platform setup rather than trying to retrofit them after your email program is already running.
Preference Centers
A preference center gives contacts control over what they receive from you. Instead of a binary subscribe or unsubscribe choice, a preference center allows contacts to select which topics interest them, such as clinical updates, product news, or events. It allows them to choose their preferred email frequency, whether weekly, monthly, or quarterly. It allows them to update their contact information and communication preferences. And it allows them to opt down instead of opting out entirely.
For medical device companies, a well-designed preference center reduces unsubscribes by giving contacts alternatives to leaving your list entirely. It also improves engagement by ensuring contacts only receive content they've expressed interest in.
International Compliance Strategy
If your medical device company markets to multiple countries, you need an international compliance strategy that addresses the requirements of each jurisdiction. The simplest approach is to default to the strictest applicable standard (typically GDPR) for all contacts, regardless of location. This eliminates the risk of applying the wrong standard and simplifies your compliance processes.
If defaulting to the strictest standard is too restrictive for your marketing objectives, implement geographic segmentation that applies jurisdiction-specific consent and communication rules based on each contact's location. This requires accurate country data in your CRM and careful configuration of your email platform's compliance settings.
Documentation and Record-Keeping
Maintain comprehensive records of your email compliance practices. This documentation should include your privacy policy and how it applies to email marketing, consent collection procedures for each acquisition channel, consent records for every contact in your database, unsubscribe processing procedures and response times, promotional review procedures and approval records, and incident response procedures for compliance violations.
Good documentation protects you in the event of a regulatory inquiry and demonstrates your commitment to compliance. It also makes it easier to train new team members and maintain consistent practices as your team grows.
Common Compliance Mistakes in Medical Device Email Marketing
Buying Email Lists Without Proper Consent
Purchasing email lists from third-party data providers is problematic under both GDPR and CASL because the contacts on those lists typically haven't consented to receive emails from your specific company. Even under CAN-SPAM, which doesn't require prior consent, purchased list quality is usually poor and leads to high spam complaint rates that damage your sender reputation.
Failing to Honor Unsubscribe Requests Promptly
All three frameworks require timely processing of unsubscribe requests: 10 business days under CAN-SPAM and CASL, and without undue delay under GDPR. Configure your email platform to process unsubscribes automatically and immediately. Manual unsubscribe processing is too slow and too error-prone for compliance.
Treating Transactional Emails as Exempt
While transactional emails such as order confirmations, shipping notifications, and account updates are generally exempt from commercial email rules, they lose their exempt status if they include promotional content. Adding a product promotion to a purchase confirmation email can transform a transactional message into a commercial one, triggering full compliance requirements.
Ignoring Consent Expiration Under CASL
CASL's implied consent expires after two years for business relationships. If you don't track consent dates and implement renewal processes, you may be sending emails to Canadian contacts whose implied consent has expired, putting you in violation of the law.
Overlooking FDA Requirements in Email Content
Many medical device marketers focus exclusively on anti-spam compliance and forget that FDA promotional regulations also apply to their email content. Every email that makes product claims must go through MLR review to ensure compliance with FDA promotional guidelines.
State-Level Privacy Laws in the United States
Beyond CAN-SPAM, medical device companies must increasingly navigate state-level privacy laws that affect email marketing practices. The California Consumer Privacy Act (CCPA) and its successor, the California Privacy Rights Act (CPRA), grant California residents specific rights over their personal data, including the right to know what data you collect, the right to delete it, and the right to opt out of its sale or sharing.
While CCPA/CPRA doesn't directly regulate email sending the way CAN-SPAM does, it affects the data practices that support your email marketing. If you collect personal data from California residents for email marketing purposes, you must disclose this in your privacy policy, honor data deletion requests that may require removing contacts from your email database, and provide mechanisms for consumers to exercise their rights.
Similar laws have been enacted or proposed in Virginia (VCDPA), Colorado (CPA), Connecticut (CTDPA), and several other states. The trend is clearly toward more privacy regulation at the state level, and medical device companies should build their data practices to accommodate the strictest applicable standards rather than retrofitting compliance as each new law takes effect.
For medical device companies that market nationally, maintaining compliance with a patchwork of state laws is a growing operational challenge. Consider implementing a unified privacy framework that meets the requirements of the strictest state law while remaining practical for your marketing operations.
Building a Culture of Email Compliance
Email compliance is not just a legal department responsibility or a technology configuration task. It requires a culture of compliance throughout your marketing organization. Train every team member who touches email marketing on the relevant regulations and your internal compliance procedures. Make compliance review a standard, non-optional step in your email production workflow. Conduct periodic audits of your email program to identify and correct compliance gaps. Stay current on regulatory changes, especially evolving state-level privacy laws in the US and updates to international frameworks.
When compliance is embedded in your team's culture and processes rather than treated as an afterthought, it becomes a competitive advantage. Healthcare professionals notice when companies handle their data responsibly and communicate ethically. That trust translates into stronger engagement, better deliverability, and ultimately, more effective email marketing.
Our healthcare SEO services work alongside compliant email programs to build a comprehensive digital marketing presence that healthcare professionals trust. At Buzzbox Media, we help medical device companies build email programs that are both high-performing and fully compliant across all applicable frameworks.